Phase III Trial of Sirolimus in IBM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mazen Dimachkie
University of Kansas Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Repatriation Hospital
Sydney, New South Wales, Australia
- Royal Northshore Hospital
Sydney, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Austin Health
Melbourne, Victoria, Australia
- St Vincent'S Hospital
Melbourne, Victoria, Australia
- Perron Institute
Perth, Washington, Australia
- Leiden University Medical Center
Leiden, Netherlands
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2022
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 14 Jan 2026
- Registered enrollment
- 140
- Registry id
- NCT04789070
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.